Age (years) | 2–85 |
Sex | Â |
 Male | 51 |
 Female | 49 |
Surgery | Â |
 Biopsy | 11 |
 Resection | 89 |
Presentation | Â |
 Primary | 79 |
 Recurrence | 21 |
IDH status | Â |
 IDH-mutant | 29 |
 IDH-wildtype | 71 |
Histologic subtype | Â |
 Astrocytoma, IDH-mutant, CNS WHO grade 2 | 3 |
 Astrocytoma, IDH-mutant, CNS WHO grade 3 | 12 |
 Astrocytoma, IDH-mutant, CNS WHO grade 4 | 5 |
 Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, CNS WHO grade 2 | 5 |
 Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, CNS WHO grade 3 | 3 |
 Glioblastoma, IDH-wildtype, CNS WHO grade 4 | 62 |
 Pilocytic astrocytoma, CNS WHO grade 1 | 5 |
 Low-grade glioneuronal tumor / Pleomorphic Xanthoastrocytoma | 1 |
 Angiocentric glioma, CNS WHO grade 1 | 1 |
 Diffuse hemispheric glioma, H3 G34-mutant, CNS WHO grade 4 | 1 |
 Diffuse low-grade glioma, MAPK pathway-altered | 1 |
 Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype | 1 |